Moody's released a new report Tuesday that reins in Wall Street expectations for the impact of GLP-1s on other industries.
Weight-loss breakthroughs all emerged from diabetes treatment. Meetings such as the coming American Diabetes Association are increasingly dominated by news on obesity drugs.
All three of the major market averages (^GSPC, ^DJI, ^IXIC) ended Monday's session in the green, with the Dow Jones Industrial Average snapping its losing streak and rising by almost half a percent. It continues to fuel the bullish sentiment with multiple financial firms raising their target goal for the S&P 500. Trump-era tax cuts due to expire in late 2025 could take center stage this election, as both leading candidates — sitting President Joe Biden and former President Donald Trump — say they are willing to extend the deadline. Eli Lilly and Company (LLY) unveiled a new manufacturing plant in North Carolina on Friday, which, according to the pharmaceutical giant, is expected to alleviate manufacturing bottlenecks for GLP-1 weight-loss drugs in high demand. For more expert insight and the latest market action, click here